$272 Million is the total value of BRIDGER MANAGEMENT, LLC's 31 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 34.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UBER | Sell | UBER TECHNOLOGIES INC | $23,425,328 | -31.7% | 509,357 | -35.9% | 8.62% | -24.6% |
| CZR | Sell | CAESARS ENTERTAINMENT INC NE | $19,834,324 | -16.2% | 427,925 | -7.9% | 7.30% | -7.5% |
| MLCO | MELCO RESORTS AND ENTMNT LTDadr | $19,435,057 | -19.0% | 1,965,122 | 0.0% | 7.15% | -10.5% | |
| CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $19,401,780 | +3.7% | 44,113 | -13.4% | 7.14% | +14.6% |
| GDDY | Sell | GODADDY INCcl a | $17,595,453 | -13.2% | 236,244 | -12.4% | 6.47% | -4.1% |
| TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $15,300,000 | +35.5% | 1,500,000 | 0.0% | 5.63% | +49.6% | |
| LLY | ELI LILLY & CO | $15,080,462 | +14.5% | 28,076 | 0.0% | 5.55% | +26.5% | |
| MS | MORGAN STANLEY | $14,856,916 | -4.4% | 181,914 | 0.0% | 5.46% | +5.6% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $14,744,176 | -1.2% | 42,400 | 0.0% | 5.42% | +9.1% | |
| Buy | BATH & BODY WORKS INC | $13,395,853 | -4.0% | 396,327 | +6.5% | 4.93% | +6.0% | |
| USFD | Buy | US FOODS HLDG CORP | $12,399,541 | +14.4% | 312,331 | +26.7% | 4.56% | +26.3% |
| BIIB | Sell | BIOGEN INC | $8,805,420 | -33.7% | 34,261 | -26.5% | 3.24% | -26.8% |
| CCK | Buy | CROWN HLDGS INC | $8,759,520 | +83.0% | 99,000 | +79.7% | 3.22% | +102.1% |
| EDR | New | ENDEAVOR GROUP HLDGS INC | $8,693,514 | – | 436,860 | +100.0% | 3.20% | – |
| ALC | Sell | ALCON AG | $7,800,553 | -47.8% | 101,227 | -44.4% | 2.87% | -42.3% |
| IMGN | IMMUNOGEN INC | $7,414,781 | -15.9% | 467,220 | 0.0% | 2.73% | -7.1% | |
| Buy | DOCEBO INC | $6,357,264 | +15.7% | 156,892 | +13.2% | 2.34% | +27.8% | |
| AKRO | New | AKERO THERAPEUTICS INC | $5,133,870 | – | 101,500 | +100.0% | 1.89% | – |
| QTRX | QUANTERIX CORP | $4,203,986 | +20.4% | 154,900 | 0.0% | 1.55% | +32.9% | |
| BAUSCH PLUS LOMB CORP | $4,160,055 | -15.5% | 245,431 | 0.0% | 1.53% | -6.7% | ||
| SHC | SOTERA HEALTH CO | $3,900,792 | -20.5% | 260,400 | 0.0% | 1.44% | -12.2% | |
| THC | New | TENET HEALTHCARE CORP | $3,854,565 | – | 58,500 | +100.0% | 1.42% | – |
| DXCM | New | DEXCOM INC | $3,620,040 | – | 38,800 | +100.0% | 1.33% | – |
| CRL | New | CHARLES RIV LABS INTL INC | $3,449,248 | – | 17,600 | +100.0% | 1.27% | – |
| KNIFE RIVER CORP | $3,330,157 | +12.3% | 68,199 | 0.0% | 1.22% | +24.0% | ||
| WILLIAMS ROWLAND ACQUISITION | $3,106,620 | +0.9% | 297,000 | 0.0% | 1.14% | +11.4% | ||
| PODD | New | INSULET CORP | $1,881,982 | – | 11,800 | +100.0% | 0.69% | – |
| GOOGL | ALPHABET INCcap stk cl a | $1,818,954 | +9.3% | 13,900 | 0.0% | 0.67% | +20.8% | |
| QURE | Sell | UNIQURE NV | $80,580 | -93.7% | 12,009 | -89.2% | 0.03% | -92.9% |
| SURROZEN INC | $30,233 | -10.9% | 61,699 | 0.0% | 0.01% | 0.0% | ||
| SURROZEN INC*w exp 08/01/203 | $19,180 | -25.5% | 466,666 | 0.0% | 0.01% | -22.2% | ||
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -24,800 | -100.0% | -0.84% | – |
| FLME | Exit | FLAME ACQUISITION CORP | $0 | – | -443,000 | -100.0% | -1.52% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -241,338 | -100.0% | -3.48% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -142,979 | -100.0% | -4.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.